GlassScriptPhysician profile
Jeffrey A Kazaglis
NPI 1295846038
$6,368.81
in general payments reported to CMS, 2019-2025
28 companies · $669 in 2025
The $669 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $613 · 2020: $578 · 2021: $1,853 · 2022: $109 · 2023: $2,303 · 2024: $243 · 2025: $669.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,698 · Travel and Lodging: $1,517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,697.84 |
| Travel and Lodging | $1,516.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,724.70 | 2019-2023 | Mako, Triathlon |
| Arthrex, INC. | $726.78 | 2021 | |
| Medwest Associates | $544.57 | 2020-2021 | |
| Smith+Nephew, INC. | $361.21 | 2019-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Electronic Waveform Lab, INC. | $349.72 | 2020-2021 | |
| Oak Med, INC. | $318.13 | 2025 | |
| Pacira Therapeutics, INC. | $302.04 | 2019-2021 | |
| Surgenex LLC | $170.13 | 2025 | Renograft, Ardeograft, Surgraft |
| Abbvie INC. | $149.98 | 2020-2021 | |
| Orthofix Medical, INC. | $119.68 | 2025 | Physio-Stim |
| Sanofi-Aventis U.S. LLC | $77.44 | 2019-2020 | |
| Djo, LLC | $60.67 | 2025 | Cmf |
| Pacira Pharmaceuticals Incorporated | $58.84 | 2020-2024 | Zilretta, Exparel |
| Amgen INC. | $58.50 | 2021-2022 | |
| Linvatec Corporation | $52.64 | 2024 | Allograft Tissue, Linvatec Shoulder Arthroscopy, Biobrace 23mm |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $45.97 | 2020-2021 | |
| Ucb, INC. | $36.42 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $32.17 | 2021-2022 | |
| Janssen Biotech, INC. | $23.34 | 2020 | |
| Lilly USA, LLC | $22.26 | 2021 | |
| Medtronic USA, INC. | $21.16 | 2019 | |
| Genzyme Corporation | $19.91 | 2021 | |
| Horizon Therapeutics Plc | $18.87 | 2022 | |
| Merck Sharp & Dohme LLC | $16.91 | 2023 | Bridion |
| Enduromed, LLC | $16.39 | 2024 | |
| Aurinia Pharma U.S., INC. | $15.59 | 2022 | |
| Heraeus Medical, LLC. | $12.69 | 2021 | |
| Zimmer Biomet Holdings, INC. | $12.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Kazaglis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.